Publication | Open Access
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations
73
Citations
43
References
2022
Year
This study develops a mouse model of immunogenic KRAS-mutant lung cancer to facilitate the investigation of optimal combinations of targeted therapies with immunotherapies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1